Skip to main content

Author: Tom Wilemon

Richmond receives legacy award from Society for Leukocyte Biology

Dec. 12, 2019—Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.

Read more


Balko lands Mary Kay Foundation grant for breast cancer research

Dec. 5, 2019—Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.

Read more


Study finds breast cancer recurrence score has different implications for men

Nov. 20, 2019—A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer

Read more


NCI ‘Moonshot’ grant to boost hereditary cancer identification

Nov. 14, 2019—VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.

Read more


VICC takes leading role in international cancer database project

Nov. 7, 2019—Vanderbilt-Ingram Cancer Center is one of three institutions launching the first phase of a collaboration to advance precision oncology through the creation of a clinico-genomic dataset with an international reach.

Read more


Grant bolsters Weiss’ pediatric thyroid cancer research

Nov. 7, 2019—Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.

Read more


Rathmell receives 2019 Eugene P. Schonfeld Award

Nov. 6, 2019—The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award.

Read more


Rathmell lands award from Lupus Research Alliance

Oct. 31, 2019—Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

Read more


High fiber, yogurt diet associated with lower lung cancer risk

Oct. 28, 2019—A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers.

Read more


Urologic cancer expert Rini joins VICC as chief of Clinical Trials

Oct. 24, 2019—Brian Rini, MD, an internationally recognized leader in genitourinary oncology, kidney cancer, and clinical drug development, is joining Vanderbilt-Ingram Cancer Center as the inaugural chief of Clinical Trials.

Read more


Research summit to highlight genitourinary cancer advances

Oct. 24, 2019—Some of the nation’s leading genitourinary cancer physicians will speak about the latest advances in care at an OncLive State of the Science Summit held in collaboration with Vanderbilt-Ingram Cancer Center.

Read more


Pietenpol, Wilson land Komen cancer research support

Oct. 24, 2019—Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Read more


Recent Stories from VUMC News and Communications Publications

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

Vanderbilt University Adult Hospital with helipad

Vanderbilt University Adult Hospital with helipad

more